FDA Inspection 1254850 — La Crosse Milling Co.
The FDA completed an inspection of La Crosse Milling Co. on Nov 22, 2024 in Cochrane, WI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 22, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cochrane, WI (United States)